Abstract
The t(14;18)(q32;q21) is the most common translocation associated with human lymphoid malignancies. Approximately 85% of follicular and 20% of diffuse B cell lymphomas possess this translocation (Fukuhara 1979, Yunis 1987). Follicular lymphoma is initially a low grade disease consisting of small resting B cells. Over time, a histologic conversion to diffuse large cell architecture and aggressive high grade lymphoma occurs frequently in patients (Horning 1989). Molecular cloning of the t(14;18) breakpoint revealed a putative proto-oncogene, Bcl-2 at 18q21 (Bakhshi 1985, Cleary 1985, Tsujimoto 1985). The translocation occurs early in pre B cell development during Ig gene rearrangement and juxtaposes Bcl-2 with the Ig heavy chain locus at 14q32 (Bakhshi 1987). This creates a Bcl-2-Ig fusion gene that is markedly deregulated resulting in inappropriately elevated levels of Bcl-2-Ig RNA and the 25 kd Bcl-2 protein (Graninger 1987, Seto 1988). Bcl-2 encodes a 25 kd integral membrane protein of an intracellular organelle (Hockenbery, submitted). We have taken several approaches to examining the functional role of Bcl-2 including overexpressing Bcl-2 in lymphoblastoid lines, growth factor dependent lines and transgenic mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ (1985) Cloning the chromosomal breakpoint of the t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:889–906.
Bakhshi A, Wright JJ, Graninger W, Seto M, Owens J, Cossman J, Jenson JP, Goldman P, Korsmeyer SJ (1987) Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84:2396–2400.
Cleary ML, Sklar J (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439–7443.
Fukuhara S, Rowley JD Varrakojis D, Golomb HM (1979) Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 39:3119–3128.
Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ (1987) Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells J Clin Invest 80:1512–1515.
Hockenbery D, Nunez G, Milliman C, Nahm M, Schreiber R, Korsmeyer SJ Bcl-2 protein blocks programmed cell death. Submitted 1990.
Horning SJ, Rosenberg SA (1984) The natural history of initially untreated low-grade non-Hodgkin ’s lymphomas. N Engl J Med 311:1471–1475.
McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphopro-liferation. Cell 57:79–88.
McDonnell TJ, Nunez G, Platt FM, Hockenbery D, London L, McKearn JP, Korsmeyer SJ (1990) Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoblogulin M and D-expressing B-cell population. Mol Cell Biol 10:1901–1907.
McDonnell TJ, Korsmeyer SJ Bcl-2-Ig transgenic mice progress from benign lymphoid hyperplasia to high grade malignant lymphoma. Submitted 1990.
Nunez G, Seto M, Seremetis D, Ferrero F, Grignani F, Korsmeyer SJ, Dalla-Favera R (1989) Growth and tumor-promoting effects of deregulated Bcl-2 in human B lymphoblastoid cells. Proc Natl Acad Sci USA 86:4589–4593.
Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602–3610.
Seto M, Jaeger U, Hockett RD, Graninger W, Bennet S, Goldman P, Korsmeyer SJ (1988) Alternative promoters and exons, somatic mutation and transcriptional deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123–131.
Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985). The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229: 1390–1393.
Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M (1987) Multiple recurrent genomic defects in follicular lymphoma: a possible model for cancer. N Engl J Med 316:79–84.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Korsmeyer, S.J., McDonnell, T.J., Nunez, G., Hockenbery, D., Young, R. (1990). Bcl-2: B Cell Life, Death and Neoplasia. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1990. Current Topics in Microbiology and Immunology, vol 166. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75889-8_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-75889-8_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75891-1
Online ISBN: 978-3-642-75889-8
eBook Packages: Springer Book Archive